B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities

B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07614022	A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)	not yet recruiting	Phase 1	26	Wake Forest University Health SciencesOTHER	1	Jun 5, 2026	clinicaltrials

Data updated 23 days agoSource updated Jun 5, 2026source: clinicaltrials